A Study of HRXG-K-1939 and Adebrelimab in Patients With Advanced Solid Tumors
Clinical trial NCT05942378 · UNKNOWN
Trial details
- NCT number
- NCT05942378
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2025-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.